NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is increasing access to the innovations of its walk-in pharmacy diagnostic technology. Recently, the company expanded from key cities in Canada’s eastern locales to sites on the western seaboard, where it hopes to diversify the profile of patients using its service. “The addition of five British Columbia outlets through Avricore’s pilot partnership with nationwide pharmaceutical chain Shoppers Drug Mart is expected to serve as an early booster stage for the company’s plans to serve 600 locations by the end of 2023,” reads a recent article. In an earlier news release, CEO Hector Bremner commented: “We’ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in a pharmacy… We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.” Notably, Avricore’s HealthTab(TM) technology, which was recently expanded to provide lab-quality results for prediabetes, also “has the flexibility to work with an array of new partners to detect additional medical conditions from additional populations as time progresses, utilizing the professional skills of neighborhood pharmacists to oversee the process and sharing the data.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer